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Abstract. Phenylpropanoids may act as nonsteroidal anti-
inflammatory drug (NSAID)-like compounds. 4-cis,8-cis-
B i s(4-hydroxy -3-methoxypheny l ) -3 ,7 -d ioxab icyc lo -
[3.3.0]octane-2,6-dione (bis-FA, compound 2), a dimer of
ferulic acid, was synthesized from ferulic acid (1), and its effect
on lipopolysaccharide (LPS)-stimulated cyclooxygenase-2
(COX-2) expression in RAW 264.7 cells was compared with
those of the parent ferulic acid (1) and of iso-ferulic acid (3-
hydroxy-4-methoxycinnamic acid) (3). LPS-induced gene
expression of COX-2 was markedly inhibited by compound 2
at a concentration of 10 ÌM and by compound 3 at 100 ÌM,
but was not inhibited by compound 1 at 100 ÌM. This
observation suggests that compound 2 may possess potent anti-
inflammatory activity. These ferulic acid-related compounds
were able to scavenge the stable 1,1-diphenyl-2-picrylhydrazyl
(DPPH) radical. The 50% inhibitory concentration for DPPH
radicals declined in the order 3 (40.20 mM) > 2 (3.16 mM)
> 1 (0.145 mM). Compound 1 possessed potent anti-radical
activity, but no COX-2 inhibitory activity, which may be a
result of enhancement of its conjugate properties by abstraction
of an H atom from the phenolic OH group, causing loss of
phenolic function. In contrast, inhibition of COX-2 expression
by compounds 2 and 3 could be caused by their increased
phenolic function, which is associated with decreased anti-
radical activity. Compounds 2 and 3, particularly 2, may have
potential as NSAID-like compounds.
o-Methoxyphenols, such as ferulic acid (4-hydroxy-3-
methoxycinnamic acid) and eugenol (4-allyl-2-
methoxyphenol), act as antioxidants, but also act as
prooxidants under certain circumstances, such as in light,
oxygen-rich and alkaline conditions. The prooxidative
activity of o-methoxyphenols can cause adverse effects
such as allergic and inflammatory reactions (1).
Dimerization of o-methoxyphenol monomers can reduce
their intrinsic prooxidative properties, because the reactive
moieties in the monomer are blocked by the other
monomer (2). We have previously synthesized a
symmetrical dimer of eugenol, bis-EUG (2,2’-dihydroxy-
3,3’-dimethoxy-5,5’-di(2-propenyl)-1,1’-biphenyl), by the
ortho-ortho coupling reaction of eugenols, and an
asymmetrical dimer of iso-eugenol (4-propenyl-2-
methoxyphenol), namely dehydrodiisoeugenol (2-(3-
methoxy-4-hydroxyphenyl)-3-methyl-5-(1-propenyl)-7-
methoxy-2,3-dihydrobenzofuran), from iso-eugenol. These
dimers showed inhibitory effects on lipopolysaccharide
(LPS)-induced cyclooxygenase-2 (COX-2) expression in
the mouse macrophage-like cell line RAW 264.7 (3, 4).
Furthermore, ferulic acid derivatives, with a molecular
structure in which the two ferulic acid moieties face each
other, were reported to suppress COX-2 promoter activity
in a concentration-dependent manner (5). These findings
strongly suggest that dimers of ferulic acid would be able
to inhibit COX-2 expression. With the aim of finding
ortho-methoxyphenol derivatives with potent anti-
inflammatory activity, a dimer of ferulic acid (bis-FA, 2)
and evaluated for its effects on LPS-induced COX-2
expression in comparison with those of ferulic acid (1) and
iso-ferulic acid (3). The activity of these compounds
against DPPH radicals was also investigated, since COX-2
inhibitory activity has previously been reported to correlate
with 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical-
scavenging activity (6-8).
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Materials and Methods
Materials. The following chemicals and reagents were obtained from
the indicated sources: ferulic acid (Tsuno Food Industrial Co. Ltd.,
Wakayama, Japan); iso-ferulic acid (Tokyo Kasei Co. Ltd., Tokyo,
Japan); Megaprime DNA labelling system and 5’-[·-32P]dCTP
(Amersham Biosciences Co., Piscataway, NJ, USA); RPMI 1640
(Invitrogen Corp., Carlsbad, CA, USA); FBS (HyClone, Logan, UT,
USA); Escherichia coli O111 B4-derived LPS (List Biological
Laboratories, Inc., Campbell, CA, USA).
Synthesis of bis-FA. Compound 2, bis-FA, was synthesized from
ferulic acid by the previously reported procedure (9-11), as shown
in Figure 1. Briefly, a solution of ferulic acid (1.94 g, 0.01 mol) in
30 ml of methanol was added slowly to a mixture of FeCl3/6H2O
in 200 ml of water, and was stirred for 48 h at room temperature in
the presence of an air stream. The reaction mixture was extracted
five times with CHCl3. The organic layer was washed with H2O and
saturated aqueous NaCl, dried over anhydrous Na2SO4 and
evaporated to give a viscous oily product, which was purified by
silica-gel column chromatography to give a colorless solid, 2, mp
212ÆC [213.8-214.7ÆC (9); 211-212ÆC (10)], in 18% yield. The 
1H-NMR (500 MHz, DMSO-d6) spectrum was in good agreement
with that in the literature (9): ‰ 3.79 (s, 6H, OCH3 x 2), 4.20 
(dd, J=1.3 and 1.3Hz, 2H, H-1/5), 5.72 (brs, 2H, H-4/8), 6.79 
(d, J=8.1Hz, 2H, H-5'), 6.86 (dd, J=8.2 and 2.1Hz, 2H, H-6'), 6.99
(d, J=2.1Hz, 2H, H-2'), 9.25 (s, 2H, OH x 2). The 13C-NMR 
(125 MHz, DMSO-d6) spectrum was similar to reported data in
acetone-d6 (10): ‰ 48.54 (C1/5), 56.27 (OCH3), 82.54 (C4/8), 111.12
(C2'), 115.92 (C5'), 119.69 (C6'), 129.47 (C1'), 147.84 (C4'), 148.33
(C3'), 175.89 (C2/6). Two-dimensional HMQC (Heteronuclear
Multiple Quantum Correlation), HMBC (Heteronuclear Multiple
Bond Correlation), and phase-sensitive NOESY (Nuclear
Overhauser Enhancement Spectroscopy) experiments proved the
structure of 2 proposed previously.
Cell culture. Cells of the murine macrophage cell line RAW 264.7,
obtained from the Riken Cell Bank, were used. They were cultured
to the subconfluent state in RPMI 1640 medium supplemented
with 10% FBS at 37ÆC under 5% CO2 in air, washed and then
incubated overnight in serum-free RPMI 1640. They were then
further washed and treated with the test samples.
DNA hybridization probe. COX-2 cDNA probes were purchased
from Cayman Chemical Co. (Ann Arbor, MI, USA). A plasmid
containing ‚-actin cDNA was obtained from the Japanese Cancer
Research Bank (Tokyo, Japan). The method used for plasmid
preparation was similar to that described previously (12).
Northern blot analysis. Cells (106/dish) in Falcon 5-cm-diameter
dishes (Becton Dickinson Labware, Franklin Lakes, NJ, USA) were
treated with test samples, and then total cellular RNA was extracted
from them by the AGPC (Acid Guanidine Phenol Chloroform)
procedure. As described earlier (13), the RNA was subjected to 1%
agarose electrophoresis and blotted onto nylon membranes (Micron
Separations, Inc., Westboro, MA, USA). The membranes were then
hybridized with cDNA probes that had been labelled with 
5’-[·-32P]dCTP by use of the Megaprime DNA labelling system.
After hybridization, the membranes were washed, dried and
exposed overnight to Kodak X-ray film (Eastman Kodak Co.,
Rochester, NY, USA) at –70ÆC. ‚-Actin was used as internal
standard for the quantification of total RNA in each lane of the gel.
Anti-DPPH radical activity. Radical-scavenging activities were
determined with DPPH as a free radical. For each inhibitor,
various concentrations were tested in ethanol. The decrease in
absorbance was determined at 517 nm for 10 min at room
temperature. Antiradical activity was calculated as the
concentration (mole/l) of inhibitor necessary to decrease the initial
DPPH radical concentration by 50% (IC50).
Results
COX-2 inhibitory activity. Northern blot assays were used to
investigate the inhibitory effects of compounds, 1, 2 and 3
on LPS-induced COX-2 gene expression in RAW264.7 cells.
Cells that had been pretreated or not with the indicated
doses of these compounds were incubated for 1 h, with or
without LPS, and then their total RNA was prepared and
analyzed by Northern blot assay for COX-2 gene expression.
Figure 2 shows that the LPS-induced gene expression of
COX-2 was clearly inhibited by bis-FA (2) at a
concentration of 10 ÌM and was also inhibited by iso-ferulic
acid (3) at the higher concentration of 100 ÌM. In contrast,
the gene expression was not inhibited by ferulic acid (1) at
a concentration of 100 ÌM. Compound 2 showed the most
potent inhibitory effect on COX-2 expression. None of the
compounds tested caused notable cytotoxicity at
concentrations up to 500 ÌM.
DPPH radical-scavenging activity. The DPPH radical-
scavenging activities of the methoxyphenol derivatives
were used to evaluate their antioxidant activity. The 50%
inhibitory concentration (IC50) was determined (Figure
3). The IC50 value declined in the order compound 3
(40.20 mM) > compound 2 (3.16 mM ) > compound 1
(0.24 mM). The DPPH radical-scavenging activities of
compounds 3 and 2 were about 200-fold less and 10-fold
less, respectively, than that of compound 1.
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Figure 1. Synthesis of bis-FA (2) by dimerization of ferulic acid. Ferulic
acid (1) was reacted with FeCl3/H2O.
Discussion
The rate-limiting step in the conversion of arachidonic acid
to prostaglandin H2, the precursor of biologically-active
prostaglandins (PGs), is catalyzed by the enzyme COX.
COX-2 is induced in a variety of cells by growth factors,
cytokines and LPS via activation of transcription factors
such as NF-kappaB. In addition, COX-2 is closely involved
in inflammation, arthritis, Alzheimer’s disease, pain and
cancer (14-17). In the present study, bis-FA (2) and iso-
ferulic acid (3) showed potent inhibition of COX-2
expression, whereas ferulic acid (1) did not. Correlations
between the ability to inhibit LPS-induced COX-2
expression in RAW 264.7 cells and anti-DPPH radical
activity have previously been reported for methoxyphenol
derivatives (6) and chalcones with phenolic OH groups (7),
with these compounds showing both antioxidant activity and
COX-2 inhibitory action. Since o-methoxyphenols possess
potent free radical-scavenging properties, they may suppress
LPS-induced gene expression partly by reducing the
oxidative stress caused by LPS treatment, possibly via
inhibition of AP-1 and NF-kappaB DNA-binding activity
(18). Nevertheless, in a study of the biological functions of
flavanones, which are also phenolic compounds, there was
little correlation between the ability to inhibit TPA (12-O-
tetradecanoylphorbol-13-acetate)-induced COX-2 expression
and anti-DPPH radical activity (8). Similarly, in the present
study, bis-FA (2) and iso-ferulic acid (3) showed potent
COX-2 inhibition without notable cytotoxicity, despite their
low anti-DPPH radical activity. We have previously reported
that ferulic acid and eugenol preferentially scavenged NO,
superoxide (O2
–) and hydroxy (OH–) radicals in addition to
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Figure 2. Regulatory effects of ferulic acid and bis-FA (A) and iso-ferulic acid (B) on LPS-induced expression of the COX-2 gene in RAW 264.7 cells.
The cells were pretreated or not for 30 min with the indicated doses of ferulic acid, bis-ferulic acid or iso-ferulic acid. They were then treated or not with
LPS at 100 ng/ml. Their total RNA was prepared 3 h after the addition of LPS. Northern blot analysis was performed with COX-2 and beta-actin cDNAs
as probes. Three independent experiments were performed and similar results were obtained. To perform the statistical analysis, the data were expressed
as relative signal intensity (the ratio of the density of COX-2 to that of actin at each concentration). There was a significant difference between bis-ferulic
acid at 10 ÌM and control (p<0.01). In contrast, no significant difference was found between ferulic acid at 10 ÌM and control. There was a significant
difference between iso-ferulic acid at 100 ÌM, 250 ÌM and 500 ÌM and control.
DPPH radicals and, on the basis of a stoichiometric study,
suggested the occurrence of dimerization for these
compounds (19). As shown in Figure 4, in biological systems
both ferulic acid and eugenol are easily oxidized by
scavenging various radical species, possibly associated with
dimerization during the oxidation process as a result of their
high resonance stability. Thus, our observation of the lack
of inhibitory effect of ferulic acid (1) on COX-2 expression
may be explained by high resonance stabilization after
reduction of the phenolic function, i.e. enhancement of its
conjugate properties after abstraction of the H atom from
the phenolic OH group. Similarly, eugenol may show
enhanced conjugate properties after radical oxidation. As
expected, eugenol shows little anti-inflammatory activity, as
characterized by NFkappaB inhibition and COX-2
inhibition (3). In contrast, iso-ferulic acid (3) predominantly
retains its phenolic function, resulting in COX-2 inhibition
(Figure 4).
In the present study, the dimer of ferulic acid, compound
2, showed potent COX-2 inhibition. We previously reported
that dehydrodiisoeugenol, an asymmetric dimer of iso-
eugenol, showed potent COX-2 inhibition and NFkappaB
inhibition at the low concentration of 0.1 ÌM, whereas iso-
eugenol, the parent monomer, did not (4). The DPPH
radical-scavenging activity of dehydrodiisoeugenol (ID50 1.30
mM) was markedly less than that of iso-eugenol (ID50 0.055
mM) and similar to that of bis-FA (ID50 3.16 mM). Overall,
these findings indicate that the ability of derivatives of
phenylpropanoids, such as ferulic acid and eugenol, to inhibit
COX-2 gene expression is dependent on their retention of a
phenolic function. Dimerization of o-methoxyphenols,
leading to high levels of phenolic function, may be a useful
tool for the development of NSAID-like compounds.
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